By analyzing tumor-conditioned media for free pro-angiogenic factors we could detect increased amounts of FGF-1 or GM-CSF in response to DC101 treatment only in the presence of WT- but not GZMB-deficient MC. The gene discussed is FGF1; the disease is neoplasm.